The diagnosis of molar pregnancy is a continuing diagnostic problem for many practicing
histopathologists who are required to examine specimens of products of conception …

For appropriate management of molar pregnancies it is important to identify those women
who have familial recurrent HM. having no fetus except in the rare case of a CHM with …

The abnormal pregnancies complete and partial hydatidiform mole are genetically unusual,
being associated with two copies of the paternal genome. Typical complete hydatidiform …

Summary Background Partial hydatidiform moles (PMs) rarely require chemotherapy and
have never previously been proven to transform into choriocarcinoma, the most malignant …

We assessed 77 twin pregnancies, comprising complete hydatidiform mole (CHM) and
healthy co-twin, to ascertain the risks to the mother and baby of continuing the pregnancy …

Background Placental-site trophoblastic tumours are a rare form of gestational trophoblastic
disease and consequently information about optimum management or prognostic factors is …

Familial biparental hydatidiform mole (FBHM) is the only known pure maternal-effect
recessive inherited disorder in humans. Affected women, although developmentally normal …

Purpose Patients with high-risk (International Federation of Gynecology and Obstetrics score
7) gestational trophoblastic neoplasia (GTN) frequently receive etoposide, methotrexate …

The p57 KIP2 protein is a cell cycle inhibitor and tumor suppressor encoded by a strongly
paternally imprinted gene. We explored the utility of p57 KIP2 as a diagnostic marker in …

Gestational trophoblastic disease represents a spectrum of pregnancy related disorders,
ranging from pre-malignant hydatidiform mole to malignant tumours, collectively referred to …